secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2026-11-06T22:08:05+00:00
Accession:  0001213900-26-116982
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Silo Pharma raises ~$850K private placement at $1.50/share; net proceeds ~$815,000
--------------------------------------------------------------------------------

- Sold 136,005 common shares at $1.50 and pre-funded warrants for 430,661 shares at $1.4999, exercisable immediately at $0.0001 until fully exercised.
- Gross proceeds ~$850,000; net proceeds expected ~$815,000 after placement agent fees and offering expenses, earmarked for working capital and general corporate purposes.
- Purchasers capped at 4.99% beneficial ownership, adjustable to 9.99% on 61 days' prior notice to the Company.
- Registration Rights Agreement requires a resale registration statement filing within 30 days and effectiveness within 60 days (90 days if SEC conducts a full review).
- Silo obtained a right-of-first-refusal waiver from H.C. Wainwright for the offering; the placement closed November 6, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026116982/0001213900-26-116982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026116982/ea0311306-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-116982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer